# Efficacy and Safety of Filgrastim in Alzheimer's Disease

> **NCT01617577** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of South Florida** · enrollment: 8 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** G-CSF; filgrastim
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01617577
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2012-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01617577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01617577, "Efficacy and Safety of Filgrastim in Alzheimer's Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01617577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*